| 000 | 01501 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517021854.0 | ||
| 264 | 0 | _c20160321 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1880-0920 | ||
| 024 | 7 |
_a10.1016/j.dmpk.2014.10.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZang, Meitong | |
| 245 | 0 | 0 |
_aEffect of CAR polymorphism on the pharmacokinetics of artemisinin in healthy Chinese subjects. _h[electronic resource] |
| 260 |
_bDrug metabolism and pharmacokinetics _cFeb 2015 |
||
| 300 |
_a123-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAntimalarials _xblood |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aArtemisinins _xblood |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 | _aConstitutive Androstane Receptor |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2B6 _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xgenetics |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aZhao, Lixia | |
| 700 | 1 | _aZhu, Fanping | |
| 700 | 1 | _aLi, Xinxiu | |
| 700 | 1 | _aYang, Aijuan | |
| 700 | 1 | _aXing, Jie | |
| 773 | 0 |
_tDrug metabolism and pharmacokinetics _gvol. 30 _gno. 1 _gp. 123-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.dmpk.2014.10.008 _zAvailable from publisher's website |
| 999 |
_c24697715 _d24697715 |
||